Agilent Technologies Names Patrick Kaltenbach, Jacob Thaysen Bus. Group Presidents; New Organization Designed to Support Cust...
21 November 2014 - 8:05AM
Business Wire
Company Announces Three Reporting Segments
as of Q1 FY15
Agilent Technologies Inc. (NYSE:A) today announced it has named
two new business presidents and realigned its businesses to better
serve customers.
Patrick Kaltenbach has been named senior vice president,
Agilent, and president of the Life Sciences and Applied Markets
Group (LSAG) business unit, which combines the former Chemical
Analysis Group and Life Sciences business. The combination will
result in most of Agilent’s instrumentation and software being in
one organization to better serve analytical laboratories with
similar needs.
Jacob Thaysen has been appointed senior vice president, Agilent,
and president of the Diagnostics and Genomics Group (DGG). This new
business unit combines the Diagnostics and Genomics businesses and
will serve the needs of clinical laboratories.
Both appointments are effective immediately. Fred Strohmeier,
who has been president of the Life Sciences and Diagnostics Group
(LDG), has announced his retirement, planned for the second quarter
of FY15. He will serve as an advisor to the company until that
time.
“I would like to thank Fred for his more than 35 years of
contributions to the company,” said Mike McMullen, Agilent
president, chief operating officer and CEO-elect. “Building on his
years of experience in life sciences, Fred most recently provided
superb leadership of Agilent’s entry into diagnostics. I wish him
the best in his retirement.”
“The organization we’re announcing today is about serving our
customers with ease, efficiency and a single voice,” McMullen
added. “By combining our businesses around market needs, rather
than technologies, we provide our customers with an easier, more
direct way to get the products, software and services they
need.
“I am excited about the addition of Patrick and Jacob as
business presidents. They are both proven leaders with deep
knowledge and exceptional customer insights across the range of our
businesses. The formation of our high-caliber executive team marks
another step toward positioning Agilent to deliver on its
outstanding growth opportunities.”
About Patrick Kaltenbach
As group president for LSAG, Kaltenbach is responsible for
leading Agilent’s life sciences and applied chemical markets
business.
Kaltenbach was most recently Agilent vice president and general
manager of the Life Sciences Products and Solutions organization,
where he had responsibility for the strategic direction and
development of all Agilent life science products.
Kaltenbach joined Agilent’s predecessor, Hewlett-Packard Co., in
1991 as an R&D engineer in the Capillary Electrophoresis
business. He has held various management positions within R&D
and senior management roles over the years. Kaltenbach holds a
degree in precision engineering from the Karlsruhe University of
Applied Science in Germany.
About Jacob Thaysen
As group president of DGG, Thaysen is now responsible for the
strategic direction and day-to-day management of Agilent’s
diagnostics and genomics business.
Thaysen was most recently vice president and general manager of
Agilent’s Diagnostics and Genomics business within LDG. He was
responsible for its overall operation, including strategic
direction, project management, sales, marketing and R&D.
Thaysen joined Agilent in 2012 as part of the Dako acquisition.
He was corporate vice president of R&D at Dako, and prior to
that a management consultant at Copenhagen Consulting Co. (now
Quartz+Co.). Previously, he was a founding partner and chief
technology officer of Cantion, a research and defense application
development company.
He holds a Ph.D. in physics from the Technical University of
Denmark.
Both Kaltenbach and Thaysen are based at Agilent’s corporate
offices in Santa Clara, California.
New Financial Reporting Segments
Starting in Q1 FY15, Agilent’s reporting segments will be Life
Sciences and Applied Markets (LSAG), Diagnostics and Genomics
(DGG), and Agilent CrossLab Group (ACG). ACG, announced in
September and headed by Mark Doak, includes services and
consumables.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in
life sciences, diagnostics and applied chemical markets, is the
premier laboratory partner for a better world. Agilent works with
customers in more than 100 countries, providing instruments,
software, services and consumables for the entire laboratory
workflow. Agilent generated revenues of $4.0 billion in fiscal
2014. The company employs about 12,000 people worldwide.
Information about Agilent is available at www.agilent.com.
NOTE TO EDITORS: Further technology, corporate citizenship and
executive news is available on the Agilent news site at
www.agilent.com/go/news.
Agilent Technologies Inc.EDITORIAL CONTACT:Michele Drake, +1
408-345-8396michele_drake@agilent.comINVESTOR CONTACT:Alicia
Rodriguez, +1 408-345-8948alicia_rodriguez@agilent.com
American Oil & Gas Common Stock (NYSE:AEZ)
Historical Stock Chart
From Jun 2024 to Jul 2024
American Oil & Gas Common Stock (NYSE:AEZ)
Historical Stock Chart
From Jul 2023 to Jul 2024